FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to a dispersible composition containing rilpivirine or a pharmaceutically acceptable acid addition salt thereof as an active substance.
EFFECT: such compositions are useful for treating HIV infection, and their inherent dispersibility properties make them applicable, in particular, for a pediatric or geriatric population.
11 cl, 10 tbl
Title | Year | Author | Number |
---|---|---|---|
LYOPHILIZED DRUG NANOSUSPENSIONS | 2012 |
|
RU2643062C2 |
POWDERS FOR PREPARING LIQUID DOSAGE FORM | 2008 |
|
RU2477133C2 |
COMBINATION, ITS APPLICATION AND METHODS FOR TREATMENT USING SPECIFIED COMBINATION | 2018 |
|
RU2755710C2 |
ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN FORM OF DISPERSIBLE TABLET CONTAINING GRANULATED ISONIAZID AND GRANULATED RIFAPENTINE, AND METHOD FOR PREPARING IT | 2014 |
|
RU2694056C2 |
CRYSTALLINE FORM OF 4-[[4-[[4-(2-CYANOETHENYL)-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL]AMINO]BENZONITRILE | 2008 |
|
RU2498979C2 |
PHARMACEUTICAL COMPOSITIONS WITH CDC7 INHIBITOR | 2019 |
|
RU2810927C2 |
(4-AMINO-2,6-DIMETHYLPHENYLSULFONYL) NITROMETHANE, (4- ACETAMIDO-2,6-DIMETHYLPHENYLSULFONYL) NITROMETHANE AND PHARMACEUTICAL COMPOSITION HAVING PROPERTIES OF ALDOSOREDUCTASE ENZYME INHIBITOR | 1992 |
|
RU2034834C1 |
PHARMACEUTICAL PREPARATIONS WITH FIXED COMBINATION OF ANALGESIC AND ANTISPASMODIC AGENTS DOSES | 2015 |
|
RU2704613C2 |
METHOD FOR PREPARING 4-(1,6-DIHYDRO-6-OXO-2-PYRIMIDINYL)AMINO-BENZONITRILE | 2006 |
|
RU2458056C2 |
NEW PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2779429C2 |
Authors
Dates
2024-09-05—Published
2017-10-23—Filed